Educación para la salud, un pilar fundamental en la adherencia al tratamiento en la dermatitis atópica. Revisión narrativa
[Health education, a fundamental pillar in treatment adherence in atopic dermatitis. Literature review]
DOI:
https://doi.org/10.5281/zenodo.18262992Palabras clave:
Dermatitis atópica, adherencia al tratamiento, calidad de vida, enfermería, educación para la salud, intervención educativaResumen
Objetivo: Establecer una relación entre la educación para la salud (EPS) y la adherencia al tratamiento en pacientes con dermatitis atópica. Métodos: Se realizó una revisión bibliográfica siguiendo el flujograma PRISMA para garantizar una síntesis rigurosa de la evidencia, revisando varias bases de datos. Se emplearon palabras claves específicas y operadores booleanos para obtener resultados precisos. Resultados: los artículos encontrados mostraron que la EPS mejora la adherencia al tratamiento en pacientes con dermatitis atópica. Se observó que los programas de educación para la salud implementados por enfermeras tienen un impacto positivo en la gestión de la enfermedad. Conclusiones: la educación para la salud es un componente para tener en cuenta en el manejo de la dermatitis atópica, mejorando la adherencia al tratamiento y la calidad de vida de estos.
ABSTRACT:
Objective: To establish a relationship between health education (HE) and treatment adherence in patients with atopic dermatitis. Methodology: A literature review was conducted using the PRISMA statement to ensure a rigorous synthesis of the evidence across multiple databases. Specific keywords and Boolean operators were employed to obtain precise results. Results: The retrieved articles demonstrated that health education improves treatment adherence in patients with atopic dermatitis. It was observed that health education programs implemented by nurses have a positive impact on disease management. Conclusions: Health education is a key component to consider in the management of atopic dermatitis, as it improves treatment adherence and the quality of life of these patients.
Citas
Silvestre Salvador J, Romero-Pérez D, Encabo-Durán B. Atopic Dermatitis in Adults: A Diagnostic Challenge. J Investig Allergol Clin Immunol. 2017;27(2):78–88.
Nutten S. Atopic dermatitis: Global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8–16.
Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–22.
Kantor R, Thyssen JP, Paller AS, Silverberg JI. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of ‘atopic dermatitis.’ Allergy. 2016;71(10):1480–5.
Baurecht H, Hotze M, Brand S, Büning C, Cormican P, Corvin A, et al. Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms. Am J Hum Genet. 2015;96(1):104–20.
Torres T, Ferreira EO, Gonçalo M, Mendes-Bastos P, Selores M, Filipe P. Update on Atopic Dermatitis. Acta Med Port. 2019;32(9):606–13.
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–82.
Galli E, Neri I, Ricci G, Baldo E, Barone M, Belloni Fortina A, et al. Consensus Conference on Clinical Management of pediatric Atopic Dermatitis. Ital J Pediatr. 2016;42(1):26.
Thomsen SF. Atopic Dermatitis: Natural History, Diagnosis, and Treatment. ISRN Allergy. 2014;2014:1–7.
Traidl S, Heratizadeh A, Werfel T, Dressler C. Online survey to identify current challenges in atopic dermatitis management and guideline implementation in German-speaking countries. Eur J Dermatol. 2021;31(6):806–12.
Zink A, Arents B, Fink-Wagner A, Seitz I, Mensing U, Wettemann N, et al. Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries. Acta Derm Venereol. 2019;99(3):263–7.
Li AW, Yin ES, Antaya RJ. Topical Corticosteroid Phobia in Atopic Dermatitis. JAMA Dermatol. 2017;153(10):1036.
Levine R, Stillman-Lowe C. Health education. Br Dent J. 2024;236(3):181–5.
Grillo M, Gassner L, Marshman G, Dunn S, Hudson P. Pediatric Atopic Eczema: The Impact of an Educational Intervention. Pediatr Dermatol. 2006;23(5):428–36.
Silverberg JI. Associations between atopic dermatitis and other disorders. F1000Res. 2018;7:303.
Argimón Pallás JM, Jiménez Villa J. Métodos de investigación clínica y epidemiológica. 4ª ed. Barcelona: Elsevier España; 2013. p. 97–105.
Programa de Habilidades en Lectura Crítica Español (CASPe) [Internet]. Alicante: CASPe; c2024 [citado 27 jun 2024]. Disponible en: https://redcaspe.org/materiales
Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332(7547):933–8.
Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582–9.
Stalder JF, Bernier C, Ball A, De Raeve L, Gieler U, Deleuran M, et al. Therapeutic patient education in atopic dermatitis: Worldwide experiences. Pediatr Dermatol. 2013;30(3):329–34.
Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol. 2009;50(2):100–6.
Singer HM, Levin LE, Morel KD, Garzon MC, Stockwell MS, Lauren CT. Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: A pilot randomized control trial. Pediatr Dermatol. 2018;35(4):453–7.
Cheong JYV, Hie SL, Koh EW, de Souza NNA, Koh MJ. Impact of pharmacists’ counseling on caregiver’s knowledge in the management of pediatric atopic dermatitis. Pediatr Dermatol. 2019;36(1):105–9.
Choi E, Tan KW, Tang F, Tan C, Chandran NS. Efficacy of targeted education in reducing topical steroid phobia: A randomized clinical trial. J Am Acad Dermatol. 2020;83(6):1681–7.
Schuttelaar MLA, Vermeulen KM, Drukker N, Coenraads PJ. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol. 2010;162(1):162–70.
Ulff E, Maroti M, Serup J. Fluorescent cream used as an educational intervention to improve the effectiveness of self-application by patients with atopic dermatitis. J Dermatolog Treat. 2013;24(4):268–71.
Gudmundsdóttir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdottir JH, Thorleifsdottir RH, et al. Engagement, Retention, and Acceptability in a Digital Health Program for Atopic Dermatitis: Prospective Interventional Study. JMIR Form Res. 2023;7:e41227.
Huynh RK, Wong HH, Aw DCW, Toh MPHS. Adherence to topical corticosteroids and moisturisers in adults with endogenous eczema in Singapore. Hong Kong J Dermatol Venereol. 2015;23(4):161–74.
Takeuchi S, Oba J, Esaki H, Furue M. Non-corticosteroid adherence and itch severity influence perception of itch in atopic dermatitis. J Dermatol. 2018;45(2):158–64.
Armstrong AW, Johnson MA, Lin S, Maverakis E, Fazel N, Liu FT. Patient-Centered, Direct-Access Online Care for Management of Atopic Dermatitis. JAMA Dermatol. 2015;151(2):154–60.
Rolinck-Werninghaus C, Trentmann M, Reich A, Lehmann C, Staab D. Improved management of childhood atopic dermatitis after individually tailored nurse consultations: A pilot study. Pediatr Allergy Immunol. 2015;26(8):805–10.
van Os-Medendorp H, van Leent-de Wit I, de Bruin-Weller M, Knulst A. Usage and Users of Online Self-Management Programs for Adult Patients With Atopic Dermatitis and Food Allergy: An Explorative Study. JMIR Res Protoc. 2015;4(2):e57.
Ozceker D, Yucel E, Sahillioglu N, Terzi O, Kocaturk EO. Topical Steroid Phobia Among Mothers of Children with Atopic Dermatitis. Asthma Allergy Immunol. 2022;20(2):87–94.
Gudmundsdóttir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdóttir JH, Thorleifsdóttir RH, et al. Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study. Dermatol Ther (Heidelb). 2022;12(11):2601–11.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Elena Violeta Iborra Palau, Raquel Tortosa Lis, Caterina Schiaffino Peña
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
En caso de que el artículo sea publicado, se permite al autor(es) mantener los derechos de autor sin restricciones y retener los derechos de publicación y distribución sin restricciones. Los artículos publicados en la revista se acogen a la licencia Creative Commons de Reconocimiento – No Comercial – Compartir Igual (BY-NC-SA). Se permite al autor(es) el autoarchivo del artículo durante su acceso como “avance de publicación (ahead of print)”.
Todo el contenido de esta revista está bajo una 